620 triệu đô la Mỹ, gia tộc Trump đã "rót tiền" vào giới tiền điện tử như thế nào?

RecBio

company

About

Focusing on major innovative vaccines with independent intellectual property rights.

Details

Last Funding Type
Series B
Last Funding Money Raised
¥1.50B
Industries
Health Care,Life Science
Founded date
Jan 1, 2012
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥1.50B
RecBio has raised a total of ¥1.50B in funding over 2 rounds. Their latest funding was raised on Nov 11, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 11, 2020 Series B ¥1.50B 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
RecBio is funded by 2 investors. HT Capital and China Everbright Investment Management are the most recent investors.
Investor Name Lead Investor Funding Round
HT Capital Series B
China Everbright Investment Management Series B